ANI Pharmaceuticals, Inc. ( ANIP) - Key Metrics
ANIP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $12.57 | $1.17 | $2.68 | $3.21 |
| 2026Q1 | $11.35 | $1.41 | $2.79 | $2.25 |
| 2025Q4 | $12.32 | $1.37 | $1.51 | $0.32 |
| 2025Q3 | $11.35 | $1.20 | $2.19 | $1.89 |
| 2025Q2 | $10.66 | $0.43 | $3.82 | $3.47 |
ANIP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 18.99 |
| 2026Q1 | 0% | 14.68 |
| 2025Q4 | 0% | 15.92 |
| 2025Q3 | 1.43% | 19.24 |
| 2025Q2 | 4.76% | 44.09 |
ANIP Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3.88% | 0% |
| 2026Q1 | 2.93% | 0% |
| 2025Q4 | 0.41% | 0% |
| 2025Q3 | 2.06% | 0.02% |
| 2025Q2 | 5.32% | 0.03% |
ANIP
Price: $71
52 week price:
Payout Ratio Range:
Earnings Per Share: 4.59 USD
P/E Ratio: 16.29
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 67658
Ebitda: 16.4 millionMarket Capitalization: 1.6 billion